A human study conducted by Vrieze et al. (2012) demonstrated that FMT could temporarily increase peripheral insulin sensitivity in patients with metabolic syndrome, which may be related to the high levels of butyrate-producing bacteria in the donor intestine (de Groot et al., 2017). Here, INS is linked to metabolic syndrome.